KD Logo

The Benchmark Company upgrades Exact Sciences Corp. (EXAS) rating to a Buy


In a filing, Exact Sciences Corp. revealed its EVP, GM., Precision Oncology Baranick Brian unloaded Company’s shares for reported $73393.0 on Apr 02 ’24. In the deal valued at $79.43 per share,924 shares were sold. As a result of this transaction, Baranick Brian now holds 13,171 shares worth roughly $0.77 million.

Then, Condella Sarah sold 2,000 shares, generating $140,000 in total proceeds. Upon selling the shares at $70.00, the EVP, Human Resources now owns 71,787 shares.

Before that, Condella Sarah sold 2,000 shares. Exact Sciences Corp. shares valued at $140,000 were divested by the EVP, Human Resources at a price of $70.00 per share. As a result of the transaction, Condella Sarah now holds 73,787 shares, worth roughly $4.34 million.

The Benchmark Company upgraded its Exact Sciences Corp. [EXAS] rating to a Buy from a a Hold in a research note published recently. A number of analysts have revised their coverage, including Guggenheim’s analysts, who began to cover the stock in mid December with a ‘”a Buy”‘ rating. Wolfe Research began covering EXAS with “an Outperform” recommendation on December 13, 2023. Piper Sandler revised its rating on October 10, 2023. It rated EXAS as “an Overweight” which previously was an “a Neutral”.

Price Performance Review of EXAS

On Monday, Exact Sciences Corp. [NASDAQ:EXAS] saw its stock fall -0.12% to $58.78. Over the last five days, the stock has lost -5.82%. Exact Sciences Corp. shares have fallen nearly -20.55% since the year began. Nevertheless, the stocks have fallen -7.35% over the past one year. While a 52-week high of $100.77 was reached on 04/02/24, a 52-week low of $56.05 was recorded on 02/28/24. SMA at 50 days reached $63.23, while 200 days put it at $69.91. A total of 2.22 million shares were traded, compared to the trading of 1.21 million shares in the previous session.

Levels Of Support And Resistance For EXAS Stock

The 24-hour chart illustrates a support level at 58.16, which if violated will result in even more drops to 57.53. On the upside, there is a resistance level at 59.87. A further resistance level may holdings at 60.95. The Relative Strength Index (RSI) on the 14-day chart is 35.94, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -5.50, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 97.53%. Stochastics %K at 2.57% indicates the stock is a buying.

The most recent change occurred on September 28, 2023 when Bernstein began covering the stock and recommended ‘”an Outperform”‘ rating along with a $83 price target.

Most Popular

[the_ad id="945"]